The forecast indicates a steady increase in the import of penicillins or streptomycins in dosage forms to Japan from 2024 to 2028, showing a consistent year-on-year growth. The values, expressed in million US dollars, demonstrate a gradual upward trend with a CAGR reflecting the health and pharmaceutical sector's continuous need in Japan. As of 2023, these imports stood below the 2024 forecast value, indicating recovery or expansion from previous levels.
- Year-on-year growth reflects a stable demand increase across the forecast period.
- The CAGR for 2024-2028 signifies a moderate yet consistent market expansion in this sector.
Future trends to watch for include potential impacts from global supply chain fluctuations, changes in healthcare policies, and innovations in antibiotic alternatives, which may alter import levels and strategies.
